Rachel J Gibson Selected Research

Mucositis

11/2015	Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.
7/2015	Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.
9/2014	Why continual update of clinical practice guidelines for cytotoxic therapy-induced mucositis is essential.
7/2014	Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.
3/2014	New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
11/2013	Emerging evidence on the pathobiology of mucositis.
7/2013	Emerging evidence on the pathobiology of mucositis.
6/2013	Biomarkers of small intestinal mucosal damage induced by chemotherapy: an emerging role for the 13C sucrose breath test.
1/2013	Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.
1/2012	Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachel J Gibson Research Topics

Disease

42	Mucositis 11/2015 - 07/2002
38	Neoplasms (Cancer) 01/2022 - 07/2002
18	Diarrhea 01/2022 - 09/2003
9	Pain (Aches) 01/2019 - 02/2015
8	Inflammation (Inflammations) 01/2020 - 06/2009
7	Weight Loss (Weight Reduction) 01/2018 - 02/2007
5	Breast Neoplasms (Breast Cancer) 04/2009 - 07/2002
3	Necrosis 01/2019 - 01/2012
3	Hemorrhage 01/2019 - 01/2017
3	Constipation 01/2017 - 09/2006
3	Vomiting 01/2017 - 01/2012
3	Stomatitis 04/2016 - 12/2005
3	Atrophy 04/2016 - 09/2003
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2013 - 10/2010
3	Colorectal Neoplasms (Colorectal Cancer) 02/2007 - 12/2005
2	Proctitis 10/2019 - 01/2013
1	Colitis 11/2019
1	Adenocarcinoma 01/2018
1	Cancer Pain 01/2017
1	Nausea 01/2017
1	Weight Gain 01/2017
1	Cognitive Dysfunction 12/2016
1	Neuroinflammatory Diseases 12/2016
1	Facial Pain (Myofacial Pain) 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Deglutition Disorders (Dysphagia) 03/2012
1	Abdominal Pain (Pain, Abdominal) 01/2012
1	Oral Ulcer (Mouth Ulcer) 05/2007
1	Hyperplasia 09/2003

Drug/Important Bio-Agent (IBA)

22	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 09/2003
8	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2006
6	CytokinesIBA 12/2016 - 08/2007
5	NF-kappa B (NF-kB)IBA 01/2013 - 12/2005
5	MucinsIBA 10/2009 - 09/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2012
3	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 07/2002
3	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2015 - 01/2013
3	Biological ProductsIBA 07/2014 - 07/2013
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2016
2	Matrix Metalloproteinase InhibitorsIBA 01/2018 - 01/2018
2	dacomitinibIBA 01/2018 - 01/2017
2	ChloridesIBA 01/2018 - 11/2016
2	Claudin-1IBA 11/2016 - 04/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2012
2	Pharmaceutical PreparationsIBA 01/2009 - 09/2003
2	Phenobarbital (Luminal)FDA Link 06/2007 - 01/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2007 - 12/2005
2	CaspasesIBA 02/2007 - 07/2006
2	Fibroblast Growth Factor 7 FDA Link 09/2005 - 07/2002
1	Toll-Like Receptor 4IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2019
1	Dextran SulfateIBA 11/2019
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2019
1	crofelemer (SP-303)IBA 01/2018
1	AZD3342IBA 01/2018
1	SB 3CT compoundIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	Naloxone (Narcan)FDA LinkGeneric 01/2017
1	AnionsIBA 11/2016
1	SecretagoguesIBA 11/2016
1	Glial Fibrillary Acidic ProteinIBA 05/2016
1	OccludinIBA 04/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2016
1	Tight Junction ProteinsIBA 07/2014
1	Suppositories (Vaginal Suppositories)IBA 01/2013
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2013
1	Oxygen (Dioxygen)IBA 01/2013
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2010
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2010
1	MitogensIBA 02/2010
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2009
1	Trastuzumab (Herceptin)FDA Link 04/2009
1	GlucuronidaseIBA 12/2008
1	Cholinergic Agents (Cholinergics)IBA 12/2008
1	Transcription Factors (Transcription Factor)IBA 06/2008
1	human FGF20 protein (velafermin)IBA 04/2007
1	Cytotoxins (Cytolysins)IBA 01/2007
1	Sucrose (Saccharose)IBA 09/2006
1	Interleukin-11 (Interleukin 11)IBA 12/2002

Therapy/Procedure

46	Drug Therapy (Chemotherapy) 01/2020 - 07/2002
16	Radiotherapy 10/2019 - 02/2004
15	Therapeutics 01/2020 - 05/2007
2	Aftercare (After-Treatment) 01/2007 - 09/2003
1	Chemoradiotherapy 10/2019
1	Hyperbaric Oxygenation 10/2019
1	Precision Medicine 01/2019
1	Drug Tapering 11/2015
1	Nutritional Support (Artificial Feeding) 09/2007